Knowledge (XXG)

Immuno-psychiatry

Source đź“ť

226:
example, giving paroxetine prior to treatment for malignant melanoma and hepatitis C was found to decrease depressive symptoms compared to persons not given paroxetine (an antidepressant).  Additional experimental support of giving an antidepressant prior to injection of endotoxin, a substance known to cause systemic inflammation) was also found to reduce self-reported symptoms of depression. In studies of antidepressant use, some persons show return to normal cytokine levels with depression treatment.  Patients with major depressive disorder treated with antidepressants have an increase in regulatory T cells and a decrease in inflammatory IL-1 beta. And even more strongly replicated, patients with increased levels of pro-inflammatory cytokines, or even genes tied to increased pro-inflammatory activity, are more likely to have antidepressant resistant depression.
48:, observe patients with neurosyphilis, syphilis that had spread to the nervous system, have decreased symptoms of psychosis after contracting malaria.  Then from the 1920s, Karl Menninger notices how many patients recovering or recovered from influenza have psychosis similar to that seen in patients with schizophrenia.  Moritz Tramer then reports how schizophrenia is associated with a child being born in the winter or spring months (when influenza is most commonly contracted).  Later in 1980s, much research is conducted associating increased rates of schizophrenia in patients with a history of prenatal, postnatal infection, and especially childhood central nervous system infections. 243:
may be related to psychosis.  Later drug studies have found that COX1 inhibition, which increases kynurenic acid,  has been reported to cause psychotic symptoms.  COX2 selective inhibitors like celecoxib, which reduce kynurenic acid, were found to reduce clinical severity of schizophrenia in non-randomized, unblinded clinical trials. While encouraging, these results remain to be confirmed in randomized clinical trials with confirmatory results before they are even considered for off-label usage.
198:
effected by the regulation of glucocorticoid receptor expression in the different regions of the brain. And multiple studies have shown that “altered HPA stress responsivity being associated with increased risk of psychopathology” such as in the study of human brain cell, gathered post-mortem, mRNA was harvested in patients who had killed themselves with either a history or a lack of a history of early childhood stresses revealed significant epigenetic changes in glucocorticoid receptor expression.
129: 260:
of mood disorders is unclear. Mixed results of some or no improvement in such studies, and the relative lack of studies recruiting sufficient numbers of patients with treatment resistant depression, a lack of studies of patients with chronic inflammation and treatment depression, and a lack of a standardized definition of an elevated chronic inflammatory state leaves more studies to be desired in pursuing the understanding of inflammation and psychiatric disorders.
1399: 1409: 222:
protein). Depression is also associated with a decrease in regulatory T cells which secrete anti-inflammatory IL-10 and TGF-beta.  Different studies have shown the that persons with depression also have lower circulating levels of IL-10, TGF-beta, in addition to the mentioned elevated levels of pro-inflammatory IL-6 in their blood stream.
205:, cause changes in glucocorticoid receptors and cortisol release similar to patients with major depression.  Both exhibit a loss of the normal cortisol rhythm of secretion throughout the day, and both show a loss of functional glucocorticoid receptors which would otherwise decrease the inflammation in the body. 189:
re-uptake and transport of glutamate by glial cells, increasing release of glutamate by astrocytes and microglia, leading to an excitotoxic state. This loss of oligodendrocytes (the astrocytes and microglia mentioned before) are a key marker in structural analysis of the brains of depressed patient populations.
221:
Many studies investigating the role of the immune system in patients with major depressive disorder found that such patients had decreased immune cell activity of natural killer cells and lymphocytes despite reliably having elevated levels of pro-inflammatory cytokines(IL-6, TNF-alpha, and C-reactive
188:
On a molecular level, cytokines effect the glutamate metabolism of the nervous system and can lead to structural changes involving microglia similar to those seen in depressed patients. TNF-alpha and IL-1, through oxidative stress via increased release of reactive oxygen and nitrogen species, impair
259:
The overall results for the many clinical trials of combinations of NSAIDS and antidepressants, proposed to more thoroughly treat standard major depressive disorder and treatment-resistant major depressive disorder, shows that the current degree of importance of addressing the inflammatory component
135:
methods of transport. Given the large and charged size of cytokines, active transport is the only direct way for the same cytokine circulating in the blood to pass through an intact blood-brain barrier. Other methods, such as activation of the endothelial cells, cytokine signaling, recruitment of
242:
Following studies revealing kynurenic acid's uniqueness as being the NMDA receptor's only endogenous (naturally found in the body) antagonist, and the fact that psychosis can be elicited from NMDA receptor antagonism, multiple studies investigated and confirmed change levels of this kynurenic acid
213:
Following studies of patients with significant chronic inflammation, like those undergoing interferon-alpha therapy for hepatitis C showing an association with depressive symptoms, not unlike Osler's "sickness behavior", more studies into major depressive disorder and its link to inflammation have
184:
Microglia make the most cytokines of all cells in the brain, respond to stress, and are likely important in the stress response as they are found to be increased in density (yet decreased in overall number) in different parts of the brain of persons who had killed themselves with major depressive
60:
provides an early documentation of the association between inflammation and changes in mood and motivation. In his 1892 book, "The Principles and Practice of Medicine," he observed that clinical patients with progressive septicemia showed "early delirium and marked mental prostration and apathy."
225:
Antidepressants have been used to infer a link between inflammation and major depressive disorder. In human studies associating the link between inflammation and depression found that giving antidepressants prior to an expected inflammatory insult decreased observed severity of depression. For
197:
The hippocampus helps regulate the HPA-axis' secretion of cortisol and has the largest number of glucocorticoid receptors in the brain. This makes it making it especially sensitive to stress and stress related increases to cortisol. Additionally, the neuroendocrine response by the HPA-axis is
229:
Through all these studies there seems to be a slight difference in symptoms of major depressive disorder with and without inflammation. Inflammation related depression tends to have less guilt/self negativity and increased slowness and lack of appetite compared to depression in persons without
64:
In 1988 while studying animals, Benjamin Hart coined the term "sickness behavior" to describe the "sleepy or depressed or inactive" state and decreased motivation to move about that sick animals displayed. A previous study from 1979, by M.J. Murry, found increased mortality when animals were
81:
Modern immuno-psychiatry theory now focuses on some variation of this model of how the environment leads to biological changes which affect the peripheral immune system and later affect the mind, mood, behavior, and response to psychiatric treatment. Stress leads to processing by the
250:
have six times the amount of a protein called Immuno-moodulin, or Imood, compared to individuals who do not contend with OCD. In addition to OCD, Imood was also found to increase symptoms of anxiety and stress, both mental health areas that have already been linked to OCD.
238:
There are ties to episodes of psychosis, and persons at risk for schizophrenia, severity of schizophrenia, and with antipsychotic therapy especially with levels of IL-6 in the blood as well as the cerebrospinal fluid of patients with schizophrenia.
72:
among persons with depression. Many of these early studies in sickness behavior showed significant differences in the many pro-inflammatory cytokines reviving interest into the role that the immune system played in psychiatric disorders.
1203: 153:(leading to decreased glutamate and dopamine release), decrease dopamine as well as decreased levels of expression of tyrosine hydroxylase (which is required to make dopamine),  increased levels of 1188: 121:
Cytokines binding receptors on peripheral afferent nerves which then conduct a message to the central nervous system in specialized regions of the brain which release their own cytokines.
44:
Since the late 1800’s scientists and physicians have noticed a possible link between the immune system and psychiatric disorders. In 1876 Alexandar Rosenblum, and later in the 1880s Dr.
68:
Beginning in the mid 1990s, investigation into the similarity in these animal “sick behavior” and persons with depression led to more and more studies showing elevated levels of
1367: 1198: 1118: 218:
from correlating levels of cytokines in the blood, correlating genes linked to inflammation to treatment response, and changes in cytokines to antidepressant therapy.
65:
force-fed after reducing their food intake in response to bacterial infection, suggesting that these changes played an essential role in fighting off infection.
1374: 1357: 1168: 466:
Jones, Brett D. M.; Daskalakis, Zafiris J.; Carvalho, Andre F.; Strawbridge, Rebecca; Young, Allan H.; Mulsant, Benoit H.; Husain, M. Ishrat (July 2020).
1123: 145:
Pro-inflammatory cytokines alter the metabolism of neurotransmitters and has been documented to effect decrease levels of serotonin, increase
1128: 974: 201:
Patients with elevated levels chronic inflammatory cytokines, (such as those with chronic hepatitis C and others undergoing injections of
86:
which releases catecholamines (dopamine and norepinephrine) that increase the number of monocytes, which respond to inflammatory signals (
1178: 87: 1163: 1138: 247: 94:, which then later reach the brain and lead to changes in neurotransmitter metabolism neuronal signaling, and ultimately behavior. 1153: 1133: 1438: 1362: 1158: 1007: 1264: 1234: 1193: 118:
Activation of endothelial cells lining the brain's vasculature which later release cytokines into the central nervous system.
149:(IDO) activity(which normally catabolizes tryptophan and consequentially decrease serotonin synthesis), increased levels of 19:
according to Pariante, is a discipline that studies the connection between the brain and the immune system. It differs from
683:"Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior" 1259: 1208: 1143: 176:, one of the down stream effects of interferon-alpha, can lead to a reversal of this decrease in tetrahydrobiopterin. 146: 338:
Khandaker, Golam M; Cousins, Lesley; Deakin, Julia; Lennox, Belinda R; Yolken, Robert; Jones, Peter B (March 2015).
1173: 83: 136:
granulocyte cells, and activation of afferent neurons work indirectly and cause the creation or release cytokines.
1352: 1249: 1244: 1017: 1012: 1296: 1291: 1183: 1022: 967: 109: 132: 933: 1384: 180:
How Cytokines Can Cause Molecular And Cellular Changes Similar to Those Seen In Patients With Mood Disorders
1331: 1067: 1027: 314: 1412: 1379: 1254: 1229: 1148: 1002: 215: 173: 91: 69: 45: 20: 172:(used in the serotonin, dopamine, and norepinephrine synthesis pathways).  However, inhibition of 1306: 1301: 1047: 1037: 997: 168:
Additionally, cytokines interferon-alpha and IL-6 can cause reversible reductions in brain levels of
738: 193:
How Inflammatory Cytokines Can Disrupt Cortisol Signaling And The HPA-axis Seen in Psychopathologies
128: 1433: 1224: 1082: 1062: 1042: 960: 410:"Inflammation and Depression: A Nervous Plea for Psychiatry to Not Become Immune to Interpretation" 169: 1398: 1326: 1057: 1402: 1286: 914: 896: 857: 839: 800: 782: 720: 702: 628: 610: 564: 546: 505: 487: 441: 377: 359: 301: 1271: 904: 888: 847: 831: 790: 774: 710: 694: 618: 602: 554: 536: 495: 479: 431: 421: 367: 351: 340:"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment" 291: 283: 202: 141:
How Cytokines Can Cause Changes To Neurotransmitter levels Which Can Sometimes Be Reversed.
124:
Recruitment of monocytes in the blood which then travel to the brain and release cytokines.
1321: 1281: 1239: 1087: 1077: 1032: 154: 23:
by postulating that behaviors and emotions are governed by peripheral immune mechanisms.
1316: 1102: 1097: 909: 876: 852: 819: 795: 762: 715: 682: 623: 590: 559: 524: 500: 467: 436: 409: 372: 339: 296: 271: 162: 355: 287: 1427: 1336: 1092: 158: 57: 28: 24: 1311: 1276: 1204:
Working Commission to Investigate the Use of Psychiatry for Political Purposes
983: 892: 778: 606: 541: 150: 900: 843: 786: 706: 614: 550: 491: 363: 115:
Active transport of cytokines in the blood to bypass the Blood Brain Barrier.
1072: 234:
Proposed roles of the immune system in Schizophrenia and Psychotic Disorders
918: 861: 804: 724: 632: 568: 509: 445: 381: 305: 698: 483: 681:
Haroon, Ebrahim; Raison, Charles L.; Miller, Andrew H. (January 2012).
426: 108:
Passing through more leaky areas of the blood brain barrier, near the
98:
Support For The Role of The Immune System Affecting Mood and Behavior
835: 591:"Inflammation at the Intersection of Behavior and Somatic Symptoms" 214:
been done. There have been many studies inferring a link between
127: 956: 820:"Reciprocal regulation of the neural and innate immune systems" 763:"Epigenetics and psychoneuroimmunology: Mechanisms and models" 468:"Inflammation as a treatment target in mood disorders: review" 952: 875:
Khandaker, G. M.; Dantzer, R.; Jones, P. B. (October 2017).
523:
Khandaker, G. M.; Dantzer, R.; Jones, P. B. (October 2017).
103:
How Cytokines Can Reach The Brain And Central Nervous System
1189:
Royal Australian and New Zealand College of Psychiatrists
761:
Mathews, Herbert L.; Janusek, Linda Witek (2011-01-01).
818:
Irwin, Michael R.; Cole, Steven W. (September 2011).
52:
History: Tying Inflammatory States to Changes in Mood
1199:
Taiwanese Society of Child and Adolescent Psychiatry
1345: 1217: 1119:
American Academy of Child and Adolescent Psychiatry
1111: 990: 934:"OCD Treatment Breakthroughs, New Therapy for OCD" 27:, for instance, is seen as malfunctioning of the 209:Associated findings in Major Depressive Disorder 185:disorder, bipolar disorder, and schizophrenia. 1169:Independent Psychiatric Association of Russia 968: 246:Recent research has shown that patients with 8: 272:"Psychoneuroimmunology or Immunopsychiatry?" 40:History Tying The Immune System to Psychosis 739:"File:Blood-brain barrier transport en.png" 230:increased levels of systemic inflammation. 161:activation and oxidative stress leading to 1124:American Board of Psychiatry and Neurology 975: 961: 953: 216:inflammation and major depressive disorder 908: 851: 794: 714: 622: 558: 540: 499: 435: 425: 371: 295: 319: 676: 674: 672: 670: 668: 666: 664: 662: 1358:Neurological conditions and disorders 1129:American Neuropsychiatric Association 660: 658: 656: 654: 652: 650: 648: 646: 644: 642: 584: 582: 580: 578: 461: 459: 457: 455: 403: 401: 399: 397: 395: 393: 391: 333: 331: 329: 327: 325: 323: 7: 595:Psychiatric Clinics of North America 255:Overall impact for clinical medicine 1179:National Institute of Mental Health 877:"Immunopsychiatry: important facts" 525:"Immunopsychiatry: important facts" 1164:Hong Kong College of Psychiatrists 1139:Campaign Against Psychiatric Abuse 408:Konsman, Jan Pieter (March 2019). 14: 1407: 1397: 1154:European Psychiatric Association 1134:American Psychiatric Association 589:Irwin, Michael R. (2011-09-01). 1408: 1159:Global Initiative on Psychiatry 1008:Child and adolescent psychiatry 90:), which causes the release of 1375:Psychiatric survivors movement 1265:Psychiatric survivors movement 1235:Controversies about psychiatry 1194:Royal College of Psychiatrists 77:Modern immuno-psychiatry model 1: 1260:Political abuse of psychiatry 1209:World Psychiatric Association 1144:Chinese Society of Psychiatry 767:Brain, Behavior, and Immunity 356:10.1016/s2215-0366(14)00122-9 288:10.1016/S2215-0366(15)00042-5 1455: 1174:Indian Psychiatric Society 932:Daze, Gilad (2021-08-19). 597:. Psychosomatic Medicine. 312: 147:indolamine-2,3-dioxygenase 92:pro-inflammatory cytokines 84:sympathetic nervous system 70:pro-inflammatory cytokines 1393: 1250:Electroconvulsive therapy 1245:Biopsychiatry controversy 1018:Cross-cultural psychiatry 1013:Cognitive neuropsychiatry 893:10.1017/S0033291717000745 824:Nature Reviews Immunology 779:10.1016/j.bbi.2010.08.009 607:10.1016/j.psc.2011.05.005 542:10.1017/S0033291717000745 1297:Psychiatric epidemiology 1292:Philosophy of psychiatry 1184:Philadelphia Association 1023:Developmental disability 270:Pariante, C. M. (2015). 110:circumventricular organs 1363:Psychiatric medications 687:Neuropsychopharmacology 165:and neurodegeneration. 1439:Psychiatric assessment 1332:Psychosomatic medicine 1068:Nutritional psychiatry 1028:Descriptive psychiatry 881:Psychological Medicine 529:Psychological Medicine 137: 1255:Insulin shock therapy 1230:Clinical neuroscience 1149:Democratic Psychiatry 1003:Biological psychiatry 344:The Lancet Psychiatry 276:The Lancet Psychiatry 174:nitric oxide synthase 131: 46:Julius Wagner-Jauregg 21:psychoneuroimmunology 1368:by condition treated 1307:Psychiatric hospital 1302:Psychiatric genetics 1048:Geriatric psychiatry 1038:Emergency psychiatry 998:Addiction psychiatry 699:10.1038/npp.2011.205 56:In modern medicine, 1225:Behavioral medicine 1083:Palliative medicine 1063:Military psychiatry 1043:Forensic psychiatry 484:10.1192/bjo.2020.43 315:Parkinson's disease 170:tetrahydrobiopterin 133:Blood–brain barrier 1327:Psychopharmacology 1058:Liaison psychiatry 427:10.3390/ph12010029 157:, leading to more 138: 17:Immuno-psychiatry, 1421: 1420: 1353:Counseling topics 1287:Pentylenetetrazol 1053:Immuno-psychiatry 887:(13): 2229–2237. 535:(13): 2229–2237. 1446: 1411: 1410: 1401: 1272:Imaging genetics 977: 970: 963: 954: 948: 947: 945: 944: 929: 923: 922: 912: 872: 866: 865: 855: 815: 809: 808: 798: 758: 752: 751: 750: 749: 735: 729: 728: 718: 678: 637: 636: 626: 586: 573: 572: 562: 544: 520: 514: 513: 503: 463: 450: 449: 439: 429: 405: 386: 385: 375: 335: 309: 299: 203:interferon-alpha 1454: 1453: 1449: 1448: 1447: 1445: 1444: 1443: 1424: 1423: 1422: 1417: 1389: 1385:Psychotherapies 1341: 1322:Psycho-oncology 1282:Neurophysiology 1240:Anti-psychiatry 1213: 1107: 1078:Neuropsychiatry 1033:Eating disorder 986: 981: 951: 942: 940: 931: 930: 926: 874: 873: 869: 836:10.1038/nri3042 817: 816: 812: 760: 759: 755: 747: 745: 743:Knowledge (XXG) 737: 736: 732: 680: 679: 640: 588: 587: 576: 522: 521: 517: 465: 464: 453: 414:Pharmaceuticals 407: 406: 389: 337: 336: 321: 317: 269: 266: 257: 236: 211: 195: 182: 155:quinolinic acid 143: 105: 100: 79: 54: 42: 37: 12: 11: 5: 1452: 1450: 1442: 1441: 1436: 1426: 1425: 1419: 1418: 1416: 1415: 1405: 1394: 1391: 1390: 1388: 1387: 1382: 1377: 1372: 1371: 1370: 1360: 1355: 1349: 1347: 1343: 1342: 1340: 1339: 1334: 1329: 1324: 1319: 1317:Psychoanalysis 1314: 1309: 1304: 1299: 1294: 1289: 1284: 1279: 1274: 1269: 1268: 1267: 1262: 1257: 1252: 1247: 1242: 1232: 1227: 1221: 1219: 1218:Related topics 1215: 1214: 1212: 1211: 1206: 1201: 1196: 1191: 1186: 1181: 1176: 1171: 1166: 1161: 1156: 1151: 1146: 1141: 1136: 1131: 1126: 1121: 1115: 1113: 1109: 1108: 1106: 1105: 1103:Telepsychiatry 1100: 1098:Sleep medicine 1095: 1090: 1085: 1080: 1075: 1070: 1065: 1060: 1055: 1050: 1045: 1040: 1035: 1030: 1025: 1020: 1015: 1010: 1005: 1000: 994: 992: 991:Subspecialties 988: 987: 982: 980: 979: 972: 965: 957: 950: 949: 924: 867: 830:(9): 625–632. 810: 753: 730: 693:(1): 137–162. 638: 601:(3): 605–620. 574: 515: 451: 387: 350:(3): 258–270. 318: 311: 310: 282:(3): 197–199. 265: 262: 256: 253: 235: 232: 210: 207: 194: 191: 181: 178: 163:excitotoxicity 142: 139: 126: 125: 122: 119: 116: 113: 104: 101: 99: 96: 78: 75: 53: 50: 41: 38: 36: 33: 13: 10: 9: 6: 4: 3: 2: 1451: 1440: 1437: 1435: 1432: 1431: 1429: 1414: 1406: 1404: 1400: 1396: 1395: 1392: 1386: 1383: 1381: 1380:Psychiatrists 1378: 1376: 1373: 1369: 1366: 1365: 1364: 1361: 1359: 1356: 1354: 1351: 1350: 1348: 1344: 1338: 1337:Psychosurgery 1335: 1333: 1330: 1328: 1325: 1323: 1320: 1318: 1315: 1313: 1310: 1308: 1305: 1303: 1300: 1298: 1295: 1293: 1290: 1288: 1285: 1283: 1280: 1278: 1275: 1273: 1270: 1266: 1263: 1261: 1258: 1256: 1253: 1251: 1248: 1246: 1243: 1241: 1238: 1237: 1236: 1233: 1231: 1228: 1226: 1223: 1222: 1220: 1216: 1210: 1207: 1205: 1202: 1200: 1197: 1195: 1192: 1190: 1187: 1185: 1182: 1180: 1177: 1175: 1172: 1170: 1167: 1165: 1162: 1160: 1157: 1155: 1152: 1150: 1147: 1145: 1142: 1140: 1137: 1135: 1132: 1130: 1127: 1125: 1122: 1120: 1117: 1116: 1114: 1112:Organizations 1110: 1104: 1101: 1099: 1096: 1094: 1093:Psychotherapy 1091: 1089: 1088:Pain medicine 1086: 1084: 1081: 1079: 1076: 1074: 1071: 1069: 1066: 1064: 1061: 1059: 1056: 1054: 1051: 1049: 1046: 1044: 1041: 1039: 1036: 1034: 1031: 1029: 1026: 1024: 1021: 1019: 1016: 1014: 1011: 1009: 1006: 1004: 1001: 999: 996: 995: 993: 989: 985: 978: 973: 971: 966: 964: 959: 958: 955: 939: 935: 928: 925: 920: 916: 911: 906: 902: 898: 894: 890: 886: 882: 878: 871: 868: 863: 859: 854: 849: 845: 841: 837: 833: 829: 825: 821: 814: 811: 806: 802: 797: 792: 788: 784: 780: 776: 772: 768: 764: 757: 754: 744: 740: 734: 731: 726: 722: 717: 712: 708: 704: 700: 696: 692: 688: 684: 677: 675: 673: 671: 669: 667: 665: 663: 661: 659: 657: 655: 653: 651: 649: 647: 645: 643: 639: 634: 630: 625: 620: 616: 612: 608: 604: 600: 596: 592: 585: 583: 581: 579: 575: 570: 566: 561: 556: 552: 548: 543: 538: 534: 530: 526: 519: 516: 511: 507: 502: 497: 493: 489: 485: 481: 477: 473: 469: 462: 460: 458: 456: 452: 447: 443: 438: 433: 428: 423: 419: 415: 411: 404: 402: 400: 398: 396: 394: 392: 388: 383: 379: 374: 369: 365: 361: 357: 353: 349: 345: 341: 334: 332: 330: 328: 326: 324: 320: 316: 307: 303: 298: 293: 289: 285: 281: 277: 273: 268: 267: 263: 261: 254: 252: 249: 244: 240: 233: 231: 227: 223: 219: 217: 208: 206: 204: 199: 192: 190: 186: 179: 177: 175: 171: 166: 164: 160: 159:NMDA receptor 156: 152: 148: 140: 134: 130: 123: 120: 117: 114: 111: 107: 106: 102: 97: 95: 93: 89: 85: 76: 74: 71: 66: 62: 59: 58:William Osler 51: 49: 47: 39: 34: 32: 30: 29:immune system 26: 22: 18: 1312:Psychiatrist 1277:Neuroimaging 1052: 941:. Retrieved 937: 927: 884: 880: 870: 827: 823: 813: 773:(1): 25–39. 770: 766: 756: 746:, retrieved 742: 733: 690: 686: 598: 594: 532: 528: 518: 475: 472:BJPsych Open 471: 417: 413: 347: 343: 279: 275: 258: 245: 241: 237: 228: 224: 220: 212: 200: 196: 187: 183: 167: 144: 80: 67: 63: 55: 43: 16: 15: 88:DAMPS/MAMPs 1434:Immunology 1428:Categories 984:Psychiatry 943:2024-08-16 748:2020-11-17 478:(4): e60. 313:See also: 264:References 151:kynurenine 25:Depression 1073:Narcology 938:BrainsWay 901:0033-2917 844:1474-1741 787:0889-1591 707:1740-634X 615:0193-953X 551:0033-2917 492:2056-4724 420:(1): 29. 364:2215-0366 919:28418288 862:21818124 805:20832468 725:21918508 633:21889682 569:28418288 510:32498754 446:30769887 382:26359903 306:26359887 1413:Outline 910:5817424 853:3597082 796:2991515 716:3238082 624:3820277 560:5817424 501:7345526 437:6469164 373:4595998 297:4580988 35:History 1403:Portal 917:  907:  899:  860:  850:  842:  803:  793:  785:  723:  713:  705:  631:  621:  613:  567:  557:  549:  508:  498:  490:  444:  434:  380:  370:  362:  304:  294:  1346:Lists 915:PMID 897:ISSN 858:PMID 840:ISSN 801:PMID 783:ISSN 721:PMID 703:ISSN 629:PMID 611:ISSN 565:PMID 547:ISSN 506:PMID 488:ISSN 442:PMID 378:PMID 360:ISSN 302:PMID 905:PMC 889:doi 848:PMC 832:doi 791:PMC 775:doi 711:PMC 695:doi 619:PMC 603:doi 555:PMC 537:doi 496:PMC 480:doi 432:PMC 422:doi 368:PMC 352:doi 292:PMC 284:doi 248:OCD 1430:: 936:. 913:. 903:. 895:. 885:47 883:. 879:. 856:. 846:. 838:. 828:11 826:. 822:. 799:. 789:. 781:. 771:25 769:. 765:. 741:, 719:. 709:. 701:. 691:37 689:. 685:. 641:^ 627:. 617:. 609:. 599:34 593:. 577:^ 563:. 553:. 545:. 533:47 531:. 527:. 504:. 494:. 486:. 474:. 470:. 454:^ 440:. 430:. 418:12 416:. 412:. 390:^ 376:. 366:. 358:. 346:. 342:. 322:^ 300:. 290:. 278:. 274:. 31:. 976:e 969:t 962:v 946:. 921:. 891:: 864:. 834:: 807:. 777:: 727:. 697:: 635:. 605:: 571:. 539:: 512:. 482:: 476:6 448:. 424:: 384:. 354:: 348:2 308:. 286:: 280:2 112:.

Index

psychoneuroimmunology
Depression
immune system
Julius Wagner-Jauregg
William Osler
pro-inflammatory cytokines
sympathetic nervous system
DAMPS/MAMPs
pro-inflammatory cytokines
circumventricular organs

Blood–brain barrier
indolamine-2,3-dioxygenase
kynurenine
quinolinic acid
NMDA receptor
excitotoxicity
tetrahydrobiopterin
nitric oxide synthase
interferon-alpha
inflammation and major depressive disorder
OCD
"Psychoneuroimmunology or Immunopsychiatry?"
doi
10.1016/S2215-0366(15)00042-5
PMC
4580988
PMID
26359887
Parkinson's disease

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑